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rhe 9th annual meeting of the Society for Cardiovascular
agnetic Resonance (SCMR) was held from January 20–
2, 2006 under sunny skies in Miami, Florida. A well-
ttended introductory physician course was held prior to the
tart of the meeting with a concurrent 3-day technologists
eeting. Over 800 physicians, scientists, trainees, nurses,
nd technologists attended the meeting which again fea-
ured parallel tracks for clinician scientists, basic scientists,
nd those interested in congenital applications. Nearly 400
bstracts were presented, including over 100 oral presenta-
ions. Seven abstract awards were chosen. A special lunch-
ime session on career development for trainees and students
as offered. In addition, a concurrent technologist program
pdated technologists from around the world in the latest in
ardiovascular magnetic resonance (CMR) technology and
pplications. New advances in imaging techniques, clinical
pplications, contrast agents, high field imaging, and mo-
ecular imaging were presented and debated. Complemen-
ary use of CMR and cardiac computed tomography (CCT)
as also discussed.
LINICAL SCIENCE
est abstracts. A session was devoted to the best clinical
ral abstracts and first prize went to Dr. Adrian Cheng of
xford University (1). Dr. Cheng and colleagues demon-
trated the feasibility of late gadolinium enhancement at
-T using a longer inversion time. The delineation of
yperenhanced infarct regions in 16 patients with prior
yocardial infarction (MI) was similar at 3- and 1.5-T.
he utility of assessing myocardial perfusion at 3-T was
ighlighted in another study of healthy subjects and patients
ith suspected coronary artery disease. The higher field
ermitted improved spatial resolution and image quality (2).
From the *University of Virginia Health System, Charlottesville, Virginia; †Oxford
niversity, Oxford, United Kingdom; ‡Johns Hopkins University, Baltimore, Mary-
and; §University of California, San Francisco, California; Children’s Hospital of
hiladelphia, Philadelphia, Pennsylvania; ¶University of Alberta, Calgary, Canada;c
nd the #Beth Israel-Deaconess Medical Center, Boston, Massachusetts.
Manuscript received March 3, 2006, accepted March 9, 2006.Other top abstracts highlighted the use of CMR in acute
I. Cardiac magnetic resonance was used to follow patients
ith acute MI randomized to bone marrow-derived stem
ell transfer or placebo (3). No improvements in left
entricular volumes or regional or global function were
ound with stem cell therapy. Cardiac magnetic resonance
as shown to be more sensitive than single-photon emission
omputed tomography in detecting acute MI among 78
atients imaged with both modalities one week after pri-
ary stenting (4). Contrast-enhanced CMR evidence of
icrovascular obstruction in acute MI was the most impor-
ant predictive parameter of cardiovascular events in a study
f 122 patients followed for 3.5 years (5).
The second place clinical oral abstract was given by Dr.
avi G. Assomull from the Royal Brompton Hospital. He
resented data from 63 patients with dilated cardiomyopa-
hy and ejection fraction 40% followed for nearly two
ears (6). The presence of mid-wall fibrosis as evidenced by
ate gadolinium enhancement was the only significant pre-
ictor of death and hospitalization on multivariate analysis.
ther top abstracts included a demonstration that late
adolinium-enhanced CMR can be applied to identify scar
rom radiofrequency ablation of the pulmonary veins in the
trial fibrillation population (7). Stress perfusion CMR was
hown to correlate well with fractional flow reserve mea-
urements in the catheterization laboratory (8). Cardiac
agnetic resonance measures of endothelial function dem-
nstrated reduced endothelial-independent dilation in
rained athletes compared with normal subjects (9).
MR and sudden death. The opening plenary session on
MR and sudden cardiac death began with an illustrative
athologic review by Dr. Christina Basso from the Univer-
ity of Padua, Italy. Dr. Basso highlighted the underlying
heme of fibrosis (an ideal target for contrast-enhanced
MR) as a substrate for sudden death in coronary artery
isease, hypertrophic cardiomyopathy, myocarditis, and ar-
hythmogenic right ventricular (RV) cardiomyopathy. Dr.
atherine Wu of Johns Hopkins University reviewed the
ole of contrast-enhanced CMR methods for the identifi-
ation of microvascular obstruction, necrosis, and cardiovas-
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Highlights of the 2006 SCMR Annual Meeting July 4, 2006:187–92ular risk in patients with prior MI. Subsequent talks
etailed how late gadolinium-enhanced CMR may identify
igh-risk patients with hypertrophic cardiomyopathy and
nfiltrative cardiomyopathies. The session concluded with
he presentation of Dr. Edward Martin (Oklahoma Heart
nstitute) on the clinical protocols to facilitate safe CMR
canning in patients with pacemakers and implantable
ardioverter-defibrillators (ICDs). Over 200 non–
acemaker-dependent patients have now been safely
canned (cardiac and non-CMR scanning), generally in
he presence of an electrophysiologist.
uidelines and reimbursement. The session on “Guide-
ines and Reimbursement” highlighted the complex issue of
MR reimbursement. A common theme was relatively low
eimbursement compared with physician effort in the U.S.,
apan, and Europe. Dr. Nathaniel Reichek (St. Francis
ospital, New York) began reviewed currently available
urrent procedural terminology codes in the U.S. and the
engthy process required to modify and update them. Dr.
artin discussed the likelihood that CMR reimbursement
ay be tied to laboratory accreditation. Dr. Eckart Fleck
German Heart Institute) reflected on the highly regulated
ituation in Europe where specific countries have laws
estricting the practice of CMR to radiologists (Germany,
elgium) while others (England, France) allow cardiovas-
ular specialists to practice CMR. Dr. Warren Manning
resented new U.S. training recommendations published by
he American College of Cardiology/American Heart As-
ociation for physicians out of training (10) and newly
pproved recommendations by the Society for Cardiovas-
ular Magnetic Resonance (SCMR) for these physicians as
ell as cardiovascular trainees (11). Both documents allow
or “out of laboratory” experiences to fulfill up to 50% of the
hree months required for level II training and are available
t the SCMR website (12).
maging of myocardial perfusion. A spirited discussion of
MR myocardial perfusion imaging was held. Standardized
rotocols were reviewed including stress and rest imaging
ollowed by late gadolinium enhancement. Limitations of
Abbreviations and Acronyms
CCT  cardiac computed tomography
CHD  congenital heart disease
CMR  cardiac magnetic resonance
DTI  diffusion tensor imaging
ICD  implantable cardioverter-defibrillator
IRON  Inversion-Recovery ON-Resonant water
suppression
MI  myocardial infarction
MRA  magnetic resonance angiography
RV  right ventricle/ventricular
SCMR  Society for Cardiovascular Magnetic
Resonance
SPIO  superparamagnetic iron oxide particles
TOF  tetralogy of Fallotrst pass perfusion imaging were discussed, including im- Bging artifacts and the need for multicenter validation.
ome argued for the superior accuracy of dobutamine stress
unction over vasodilator stress perfusion. A robust experi-
nce in private practice in Hong Kong was demonstrated.
ertinent abstracts included validation of perfusion imaging
gainst fractional flow reserve measure at catheterization
ith a sensitivity and specificity of 94% and 83%, respec-
ively, for significant stenoses in 42 patients (13). Over 400
atients with a negative adenosine stress perfusion study had
n event-free survival of 99% over a period of at least 6
onths (14). Quantitative measures of myocardial blood
ow CMR in 27 patients undergoing percutaneous coronary
ntervention demonstrated that mean blood flow is lower in
egments with scar and is related to scar transmurality (15).
ascular/plaque imaging. An exciting session on the use
f CMR angiography and plaque imaging for atheroscle-
otic vascular disease was kicked off by Dr. Sanjay Rajago-
alan (Mt. Sinai, New York). Other speakers discussed new
pproaches to magnetic resonance angiography (MRA) in
he peripheral and carotid arteries. Novel CMR spectro-
copic (16) and perfusion methods (17) for assessing calf
uscle physiology in peripheral arterial disease were re-
iewed. Finally, the role of carotid plaque imaging in clinical
rials was discussed including the additive role of gadolin-
um contrast. Abstracts of particular interest in this arena
ncluded a demonstration that CMR could detect signifi-
ant changes in aortic distensibility, brachial artery flow-
ediated dilation, and aortic atherosclerosis within 3
onths of starting statin therapy (18). In addition, a
2-channel 1.5-T magnetic resonance scanner using multi-
oil technology showed excellent results for lower extremity
RA with an extended field of view (19).
MR and CCT. This session addressed the unresolved
uestion of the relative importance of CMR and CCT in
he evaluation of coronary artery disease. Dr. Hajime
akuma discussed the benefit of CMR and effectively
escribed the limitations and benefits compared with CCT.
oth his group (20) and others (21) have published prom-
sing results with whole heart CMR imaging, akin to the
hree-dimensional computed tomography angiography ap-
roach but acquired using respiratory navigators. His group
escribed a sensitivity of 82%, specificity of 90%, and
iagnostic accuracy of 87% in 113 patients. In general, the
uality of whole heart coronary MRA is more variable and
ess predictable than single breath-hold coronary computed
omography angiography.
Dr. Daniel Berman presented recent experiences with
4-detector CCT coronary imaging. Spatial resolution with
CT is better than for coronary magnetic resonance, and it
as an acquisition time of seconds. In several published
apers using 64-detector CCT, sensitivities and specificities
ompared with those of X-ray angiography have ranged
rom 90% to 100%. Coronary arterial calcification remains a
ignificant limitation as does the need for iodinated contrast
edia in patients with renal insufficiency. Drs. Sakuma and
erman agreed that for now, CCT will likely be the
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July 4, 2006:187–92 Highlights of the 2006 SCMR Annual Meetingechnique employed in most patients, while CMR will be
sed for patients with high calcium scores and renal insuf-
ciency. Cardiac magnetic resonance may also be preferred
hen additional information, such as myocardial viability, is
ought or repeated testing is anticipated.
entricular remodeling: insights from CMR. A session
as devoted to the use of CMR as the window to the
emodeling heart. Dr. Martin St. John Sutton (University of
ennsylvania) presented the development of this field using
chocardiography. The CMR speakers discussed remodel-
ng in the setting of MI and dilated cardiomyopathies. The
MR assessment of reverse remodeling with both medical
nd revascularization strategies was elucidated. Results in a
otal of more than 300 patients presented at the meeting
howed a significant incremental prognostic value of infarct
ize quantification by CMR for predicting major adverse
ardiac events after MI (5,22). Although larger infarcts are
ssociated with adverse outcomes, a pilot trial indicates that
atients, despite infarcts involving more than 40% of the left
entricular mass, may have a favorable outcome (23). Mi-
rovascular obstruction in acute MI was again shown to be
strong predictor of outcome (24).
ASIC SCIENCE
est abstracts. Matthias Stuber, PhD, of Johns Hopkins
niversity won first prize for a novel approach to creating
ositive contrast from supermagnetic nanoparticles called
nversion-Recovery ON-Resonant water suppression
IRON) (25). By suppressing the on-resonant protons
ithin a certain bandwidth, signal enhancement was pro-
uced from the off-resonant protons in proximity to the iron
anoparticles. Second prize was presented to Khaled Z.
bd-Elmoniem, MSc, from the same institution for the
mproved accuracy of planar strain maps through correction
f the false strain component generated by through-plane
otion using a tagging methodology capable of tracking
hree-dimensional myocardial displacement in all points in
n image plane (26).
Two other top basic abstracts focused on diffusion tensor
maging (DTI), a technique used to non-invasively charac-
erize cardiac fiber orientation. In one study, three-
imensional deconstruction of cardiac tissue architecture
as performed on an isolated canine heart (27) while
nother focused on improving in-vivo DTI, a challenge due
o cardiac and respiratory motion and susceptibility gradi-
nts (28). Other top abstracts focused on spectroscopy. One
emonstrated significant derangements in cardiac 31phos-
horous energy metabolism in patient with left ventricular
oncompaction (29). Another used ultrashort echo time
hemical shift imaging for the efficient quantitation of
yocardial 23Na concentrations (30). One group pro-
osed a two-dimensional balanced steady state free pre-
ession technique for the detection of blood-oxygen
evel-dependent contrast in a model of coronary occlusion
ith excellent temporal and spatial resolution (31). The ufficacy of P947, a short peptide ligand for matrix
etalloproteinases, was established for the detection of
therosclerotic plaque in ApoE knockout mice (32).
eal-time acquisition of black-blood cine cardiac images
t 3-T was demonstrated using a real-time sequence with
timulated echos (33).
ellular and molecular imaging/novel contrast agents.
he cellular and molecular imaging session provided an
verview of contrast ultrasound, bioluminescence, radionu-
lide, and CMR imaging approaches. While CMR tech-
iques for stem cell tracking show promise for rapid
ransition to the clinical realm, methods for studying gene
xpression and molecular imaging of atherosclerotic pro-
ression are increasingly available. In a session devoted to
ovel contrast agents, an overview was presented of the
echanisms of gadolinium and iron oxide contrast as well as
heir use as targeted agents for plaque detection and cell
racking.
The advantages of high spatial resolution and targeted
MR contrast agents are being pursued. One such agent, an
V3-integrin–targeted paramagnetic nanoparticle contain-
ng the antiangiogenic agent fumagillin, was shown to
onitor atherosclerotic progression and response to therapy
n a rabbit model (34). Using a monoclonal antibody
argeting platelet/endothelial cell adhesion molecule-1
ound to a superparamagnetic iron oxide particles (SPIO),
elective uptake of the agent in mouse infarction was shown
35). In a preclinical MI model, SPIOs were used to
xogenously label mesenchymal stem cells and study their
igration after transmyocardial injection, suggesting that
argeting of the peri-infarction zone is preferred (36).
ntravenous ultrasmall and micrometer-sized SPIOs were
sed to track macrophage infiltration and transplant rejec-
ion in a heterotopic heart and lung rat transplantation
odel (37). The first in-vivo fluorescent tomography and
MR of a magnetofluoroscent nanoparticle uptake by
acrophages in mouse infarction shows promise as a novel
gent for targeting inflammation (38).
arallel and other novel imaging techniques. One session
as devoted to imaging methods to accelerate image acqui-
ition in both the spatial and temporal domain (e.g.,
nhanced parallel imaging, spiral imaging, and k-t Blast
echniques). These advances are providing faster CMR
maging and real-time image acquisition schemes. The
sefulness of k-t Blast for accelerated image acquisition for
rst-pass contrast-enhanced CMR during rest and adeno-
ine stress was demonstrated in patients with suspected
oronary artery disease before catheterization (39). Using a
rototype 32-receiver channel 1.5-T MR scanner, the
easibility of acquiring three-dimensional cine CMRs in a
ingle breath-hold using parallel imaging for assessing
ardiac structure and function was demonstrated (40). Several
ew imaging techniques for the visualization of iron oxide
articles were presented. One technique, called GRadient
cho Acquisition for Superparamagnetic Particles (GRASP),
ses a phasing/dephasing technique to render a bright signal
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Highlights of the 2006 SCMR Annual Meeting July 4, 2006:187–92nd was applied to the imaging of ferritin deposition in a rabbit
arotid injury model (41). The IRON technique for positive
nhancement of SPIOs was combined with fat suppression for
ron-oxide-labeled stem cell detection in angiogenesis (42).
nterventional CMR. A session was devoted to advances
n interventional CMR. Cardiac magnetic resonance shows
romise for targeting of gene and stem cell therapy to
pecific areas of the heart such as the peri-infarction zone or
therosclerotic plaque. Electrophysiology applications are
aking advantage of hybrid X-ray/magnetic resonance sys-
ems to obtain detailed anatomy of the pulmonary veins by
MR for guiding X-ray ablation therapy. Similarly, for
ediatric applications, CMR can be used to obtain high-
esolution anatomical details of congenital abnormalities
hat can be fused with X-ray images to guide therapy and
oncurrently decreasing the radiation dose. Safety of mag-
etic resonance delivery devices, ICDs, and pacemakers
emains a concern. Recent studies suggest that more mod-
rn pacemakers and ICDs have been scanned without
dverse events. However, more robust testing of pacemaker
ead heating remains warranted especially as CMR moves to
igher field strengths.
ew developments in murine CMR. Given the enormous
mportance of transgenic mouse models, a full session was
edicated to this topic including an update on advanced
ools for the assessment of left ventricular remodeling
ost-MI, spectroscopy to investigate myocardial metabo-
ism, and molecular contrast agents for targeting atheroscle-
osis or transplant rejection. Interesting abstracts included
he use of strain analysis by tagged CMR to quantify the
rogression of mechanical dyssynchrony during remodeling
n a post-MI mouse model (43). Infarction alone leads to
ignificant dyssynchrony, which does not change signifi-
antly over time. Mice with chronic pressure-overload from
ortic constriction showed a reduced ejection fraction,
ncreased left ventricular mass and end-diastolic volume,
hile cardiac phosphocreatine/adenosine triphosphate ra-
ios were decreased (44). Murine molecular CMR is becom-
ng increasingly important, and several abstracts reported on
sing different agents in mouse models including SPIOs (35),
agnetofluoroscent nanoparticles (38), and gadolinium-based
argeted contrast agents (45).
OMBINED CLINICAL AND BASIC SCIENCE
.5- versus 3-T— complementary or competitive? 3-T
ardiac imaging was well represented with its status as
promising but unproven” in 2005 advancing to “accepted
nd appropriate” in 2006. Cardiac magnetic resonance at
-T can address most of the basic clinical questions that are
outinely answered at 1.5-T (function, late enhancement),
nd that in certain situations CMR at 3-T may be superior
such as for coronary imaging and tagging) or vastly superior
qualitative perfusion and 31P-MR spectroscopy) to 1.5-T.
early 10% of the abstracts reported on imaging at 3-T,
learly representing a growth area in CMR. Some were tethods based in healthy subjects (46), but 12 abstracts
resented data from over 100 patients, including children
nd patients with stents and sternal wires. Abstracts com-
aring 3- and 1.5-T described general increases in signal-
o-noise ratio at 3-T (47,48), which are difficult to quantify
recisely owing to differences between coil designs and
ther system characteristics. Specifically, it was shown that
uantification of irreversible damage by late enhancement
as similar for 1.5- and 3-T (1), and that perfusion imaging
llows for higher resolution at 3-T (2). Electrocardiographic
ating was not reported as being problematic, alleviating
revious concerns over elevated magnetohydrodynamic
ignals.
uantification in CMR. A session devoted to quantifica-
ion in CMR reviewed state-of-the-art approaches to quan-
ifying infarct size with late gadolinium enhancement as
ell as regional function with tagging, phase velocity map-
ing, and displacement encoding methods. In addition, flow
uantification with phase velocity imaging and quantifica-
ion of first-pass myocardial perfusion with deconvolution
ethods were discussed.
ONGENITAL HEART DISEASE (CHD)
multiday program was dedicated to CMR in CHD. The
Controversies” session prompted vigorous discussions re-
arding whether CMR and CCT were competing or
omplementary, if single ventricle patients require routine
atheterization during staged Fontan reconstruction or the
erits of non-geometric echo-Doppler techniques when
ompared with CMR for ventricular function. The unique
echnical challenges facing the CMR imager in CHD were
ddressed. A session devoted to CMR in adult CHD
iscussed issues regarding coarctation of the aorta, the
ystemic RV, the Fontan circulation, and tetralogy of Fallot
TOF) in this aging patient population.
The top prize in the best abstract session in CHD
ompared perfusion imaging in 19 children with coronary
ngiography and found that it was feasible and concordant
ith angiographic findings (49). Tetralogy of Fallot was the
ubject of four reports in this session. One group reported
hat restrictive physiology was associated with worse exer-
ise tolerance and that repair at a young age did not protect
atients from RV diastolic dysfunction (50). Myocardial
elocimetry was used to demonstrate decreased biventricular
elocities of TOF patients when compared with patients
ith d-transposition of the great arteries (51). Myocardial
carring by late gadolinium enhancement in TOF correlates
ith life-threatening arrhythmias (52). A study of regional
all motion abnormalities of the RV in TOF found that the
V outflow tract is principally responsible for global RV
ysfunction (53). Two reports championed the concept that
eneral anesthesia is not necessary for keeping pediatric
atients motionless in the scanner, using either deep seda-
ion (54) or a modified video display system (55). A new
echnique utilizing parallel imaging and the “CENTRA-
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July 4, 2006:187–92 Highlights of the 2006 SCMR Annual Meetingeyhole” method was presented, which allowed for time-
esolved, “cine,” three-dimensional contrast-enhanced
MR angiography (56).
onclusions. The 2006 meeting of the SCMR was high-
ighted by major advances in the field including the growth
f applications at 3-T, important prognostic information in
atients with MI and dilated cardiomyopathies, the use of
MR in major clinical trials of stem cell therapies, novel
echniques for rapid imaging and targeting contrast agents,
nd new applications in murine models. The interaction of
MR and CCT will continue to be defined by advances in
oth fields. The 10th annual Scientific Sessions of the
CMR (February 2 to 4, 2007 in Rome, Italy) will be a
ombined meeting with the European CMR Working
roup and promises to provide some answers and foster
ore debate as clinical and research applications of CMR
ontinue to evolve.
eprint requests and correspondence: Dr. Christopher M.
ramer, University of Virginia Health System, Departments of
edicine and Radiology, Lee Street, Box 800170, Charlottesville,
irginia 22908. E-mail: ckramer@virginia.edu.
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